A new pharmacogenomic study identifies genetic pathways, particularly involving DRD3, BDNF, and CREB1, through which GLP‑1 receptor agonists (e.g., Ozempic) may induce depressive symptoms and suicida… [+5348 chars]
Popular Weight Loss Drugs Like Ozempic May Trigger Depression, Doctors Warn - SciTechDaily
Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic testing. A study published in Current Neuropharmacology reveals a potential link between Glucagon-like Peptide-1 (GLP-1) receptor agonists, …
Source:SciTechDaily
Published:
Related News
This Is the Vaccine Story RFK Jr. Doesn’t Want You to Hear - The Bulwark
The Trump administration says we should learn from other countries. Maybe they should have looked someplace besides Denmark.
The Bulwark•Jonathan Cohn
Close to 90% of Americans have silent heart disease, AHA says - NewsNation
The AHA acknowledged that Cardiovascular-Kidney-Metabolic syndrome (CKM) is a condition that involves a chain reaction inside the body.
Newsnationnow.com•Rob Taub
This Forgotten Cancer Vaccine’s Results Were So Unusual Scientists Revisited It 20 Years Later - SciTechDaily
New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody.
SciTechDaily